Skip to main content
Fig. 3 | Chinese Medicine

Fig. 3

From: P2Y12 receptor as a new target for electroacupuncture relieving comorbidity of visceral pain and depression of inflammatory bowel disease

Fig. 3

P2Y12 shRNA treatment downregulated the expression of P2Y12 and IL-1β in the mPFC. a Representative immunoblots of P2Y12 and β-actin protein expression in the mPFC. b Representative immunoblots of IL-1β and β-actin protein expression in the mPFC. c Enzyme-linked immunosorbent assay results. d Densitometric analysis of P2Y12 protein normalized to the loading control. e Densitometric analysis of IL-1β protein normalized to the loading control. Data are presented as the mean ± SEM (n = 3–4). *p < 0.05, compared with the control + vectors group; #p < 0.05, compared with the TNBS + vectors group

Back to article page